Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 1, Issue 2, pp. 162-177
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 13, 2020
- Revision received April 22, 2020
- Accepted May 11, 2020
- Published first July 7, 2020.
Article Versions
- Previous version (July 7, 2020 - 05:45).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Charles R. Schmidt1,
- Nicholas J. Achille2,
- Aravinda Kuntimaddi1,
- Adam M. Boulton1,
- Benjamin I. Leach1,
- Shubin Zhang2,
- Nancy J. Zeleznik-Le2,3,* and
- John H. Bushweller1,*
- 1Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia.
- 2Department of Cancer Biology, Loyola University Chicago, Maywood, Illinois.
- 3Department of Medicine, Loyola University Chicago, Maywood, Illinois.
- ↵*Corresponding Authors:
John H. Bushweller, University of Virginia, P.O. Box 800736, 1330 Jefferson Park Avenue, Charlottesville, VA 22903. Phone: 434-243-6409; Fax: 434-982-1616; E-mail: jhb4v{at}virginia.edu; and Nancy J. Zeleznik-Le, Loyola University Chicago, 2160 S. First Avenue, Bldg. 112, Rm. 337, Maywood, IL 60153. E-mail: nzelezn{at}luc.edu
September 2020
Volume 1, Issue 2
Volume 1, Issue 2
BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity
Jump to section
Advertisement